Trial Watch: Chemotherapy with immunogenic cell death inducers. - Wikidata - awgldk - TriplyDB

Trial Watch: Chemotherapy with immunogenic cell death inducers.

Trial Watch: Chemotherapy with immunogenic cell death inducers.

http://www.wikidata.org/entity/Q55260834

about

Advances in inducing adaptive immunity using cell-based cancer vaccines: Clinical applications in pancreatic cancer The effect of chemotherapy on programmed cell death 1/programmed cell death 1 ligand axis: some chemotherapeutical drugs may finally work through immune response Cancer Dormancy: A Regulatory Role for Endogenous Immunity in Establishing and Maintaining the Tumor Dormant State Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer Anticancer drugs for the modulation of endoplasmic reticulum stress and oxidative stress Chloroquine and hydroxychloroquine for cancer therapy Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy Cancer vaccines Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapy Trial Watch-Oncolytic viruses and cancer therapy Trial Watch-Immunostimulation with cytokines in cancer therapy Trial Watch: Proteasomal inhibitors for anticancer therapy A2aR antagonists: Next generation checkpoint blockade for cancer immunotherapy Maytansine-loaded star-shaped folate-core PLA-TPGS nanoparticles enhancing anticancer activity Metabolomics of Therapy Response in Preclinical Glioblastoma: A Multi-Slice MRSI-Based Volumetric Analysis for Noninvasive Assessment of Temozolomide Treatment Trial Watch: Peptide-based anticancer vaccines.Novel immune checkpoint blocker approved for the treatment of advanced melanoma A view on dendritic cell immunotherapy in ovarian cancer: how far have we come?Combinatorial strategies for the induction of immunogenic cell death.Metronomic cyclophosphamide eradicates large implanted GL261 gliomas by activating antitumor Cd8(+) T-cell responses and immune memory The Cytolytic Amphipathic β(2,2)-Amino Acid LTX-401 Induces DAMP Release in Melanoma Cells and Causes Complete Regression of B16 Melanoma In vivo potential of recombinant granulysin against human tumors.Profiling networks of distinct immune-cells in tumors.Chemosensitization strategies for the treatment of lung cancer.Doubling the blockade for melanoma immunotherapy Differences in the composition of the immune infiltrate in breast cancer, colorectal carcinoma, melanoma and non-small cell lung cancer: A microarray-based meta-analysis.The oncolytic peptide LTX-315 triggers necrotic cell death.Yet another pattern recognition receptor involved in the chemotherapy-induced anticancer immune response: Formyl peptide receptor-1.Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy.Tasquinimod modulates tumor-infiltrating myeloid cells and improves the antitumor immune response to PD-L1 blockade in bladder cancer The prognostic and predictive value of the lymphocyte to monocyte ratio in luminal-type breast cancer patients treated with CEF chemotherapy Targeting Protein Kinase CK2: Evaluating CX-4945 Potential for GL261 Glioblastoma Therapy in Immunocompetent Mice.Rationale for combining immunotherapy with chemotherapy.Targeting the immune system to treat lung cancer: rationale and clinical experience.The evolving paradigm of cell-nonautonomous UPR-based regulation of immunity by cancer cells.Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?Cellular immunity augmentation in mainstream oncologic therapy Clinical overview of metronomic chemotherapy in breast cancer.Nivolumab for treating non-small cell lung cancer.

P2860

Q26749451-12293D40-DDB4-413A-AF17-D1FE9F8D01E1 Q26766066-3CB211AE-824F-4467-8FFC-CB78D4697724 Q26782573-4803A47D-033B-4644-9798-9A4CD258E428 Q26795466-6C3DF649-B0AB-41FB-AFD5-17654861F497 Q26799265-6D998C50-5E03-41C7-8488-820B95219A8D Q26827797-0673F104-204E-415B-A6A9-0CA7B183C095 Q26996518-4A4243D4-449E-484A-A403-BBCC677FADDA Q27004011-5F48081C-9C32-4F23-A24B-A273FF3BDAE1 Q27024438-C6A6FE8C-42B9-4050-B5E5-EA04FE07634F Q28067939-BF5C1C13-5AC9-47C1-BC57-46AFF8A0C2FE Q28072347-38BB4C76-05EE-4EC9-BBF8-CB17A34678F9 Q28078725-82BAE288-C2F1-4E47-A355-B3C600F9885F Q28082910-F9A68CCD-C806-4150-9401-F2CCB1D9239B Q28087576-28138015-A90F-4EA5-9C85-7040DDB5B4B0 Q28654242-495265EF-2C2A-4B39-90BF-26F5BCEE41F4 Q33844943-6992E6BD-CB74-4641-967B-B50AE35A458B Q34483345-544A4B18-9E9A-46EC-8426-00065D66F321 Q34936394-1CACA370-E4BA-48BD-8426-70868BABA1BD Q35475233-E7C79E89-3235-459D-A345-C0AAC4B42A66 Q35535140-4A9AF26F-91A2-4C87-82A8-9A5F534A811B Q35799297-D4535E2D-6CA5-4A46-9727-5478476C0F62 Q35924903-84A68E06-FEFB-42A2-9B64-1EF6AF9761F3 Q36060311-302AFC52-FC5B-4185-A59A-87CCAF7EC975 Q36067826-8569FBC0-AD79-4314-A031-E781F8F5542D Q36352608-57E6392D-659E-4415-8C7E-5A71D45125F2 Q36597356-24B6AE09-6F8D-46CF-9785-6E538CFD3E70 Q36710922-A2F6C19B-92D4-44B1-AC5B-D642A6BCA06B Q36780793-AE46D295-471F-4254-B6B6-C8111E8ACDB4 Q37012744-12DA375C-0E0F-4456-9C48-2D8CECC03B53 Q37079141-4BEFA4F5-1CA1-44CF-BEB6-9401BB5CE7DD Q37113485-0A43E4DE-CB68-4919-99DC-506476512D8B Q37376414-1A6C9DD0-9C59-44AD-936B-73311E345515 Q37731326-FD4E6148-1901-4AA6-A02D-A2B913A2814A Q38389326-88F86190-B7A4-428A-84EC-B72DFD04DAAB Q38397629-1D25021B-C2AE-4982-8E7D-D0536CE25922 Q38429699-B057EC8F-DF09-49F4-87AA-C51FC5C65BE3 Q38447992-647E05CA-EA6D-46F7-9154-11D59F9D2539 Q38557424-4BF4E865-D5D0-47B3-8F3B-A29C025C8098 Q38560651-5D50D776-698D-42F1-B05B-DC331256720D Q38634988-1C315A8F-764A-4157-B6C2-2231EAD3A34C

P2860

Trial Watch: Chemotherapy with immunogenic cell death inducers.

http://www.wikidata.org/entity/Q55260834

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Trial Watch: Chemotherapy with immunogenic cell death inducers.

@en

Trial Watch: Chemotherapy with immunogenic cell death inducers.

@nl

type

label

Trial Watch: Chemotherapy with immunogenic cell death inducers.

@en

Trial Watch: Chemotherapy with immunogenic cell death inducers.

@nl

prefLabel

Trial Watch: Chemotherapy with immunogenic cell death inducers.

@en

Trial Watch: Chemotherapy with immunogenic cell death inducers.

@nl

P1433

Q55260834-9957E61A-5E21-4575-A01A-AEBA4E69CD57

P1476

Q55260834-784F7C5D-3743-482C-97FF-6FC35AA92054

P2093

Q55260834-1E8A79A8-E33A-4102-9CF8-50C3FFD7022B

Q55260834-6A734342-0C18-46D5-BDA8-AE8BA0587437

Q55260834-99E4C57B-5301-414C-9487-85D9EFB7C456

P2860

Q55260834-0063C2B5-1C0A-4EBF-81D0-20818852EF4E

Q55260834-0550CA5F-28AE-4EC4-9B86-35FCBF3A2D4D

Q55260834-06E5EC3B-AA50-497C-9134-49BC5C566B88

Q55260834-07FA9DE5-02F3-46B7-A451-139EF764D782

Q55260834-0A3466B9-21E3-482F-BEE6-08752E5761A9

Q55260834-0A3ACAA8-F5CD-47BF-A654-A17273B487F5

Q55260834-0B9BE8AB-BE2C-4623-A370-CF716FE73FDA

Q55260834-101FE445-2FFD-4494-A5EF-BC8B13CAE760

Q55260834-107C785A-A237-4190-B742-31A52CB8269C

Q55260834-11164AE1-3AB2-41DF-B22A-39E33FDD7912

P304

Q55260834-B6CAF4D4-7E4F-4986-99A3-3E2970A558BB

P31

Q55260834-91325933-2EAD-4EB7-8D1A-1B867F319E7F

P356

Q55260834-644E0E9B-A00C-475B-B913-516B64552BE4

P433

Q55260834-D9450C52-A4F3-443A-95BF-25D0A84CC889

P478

Q55260834-A2360847-6C14-4B27-84F1-53833FE483E5

P50

Q55260834-38198EEF-5D8A-4357-8D79-B83F20F467B6

Q55260834-5F4D4425-E60E-47A1-BF88-DF14A75E6783

Q55260834-8EAF5242-CF6A-4A4D-B774-F2F05DBDC1CE

Q55260834-CA7BAD02-1DF6-44D1-A27D-7774C3410E9B

Q55260834-D5EE7ADF-1DA1-4108-B063-93D177296036

Q55260834-FA80B7CB-8616-4061-8C3F-9B2A8A6821B9

P577

Q55260834-2859653B-456D-4195-9B26-5864DAA82A87

P5875

Q55260834-B9EEE384-4C4E-4599-8024-1AF66305AC2D

P698

Q55260834-946A1B0B-0A86-4404-8E1B-8E88C5A66456

P921

Q55260834-46A645CA-3259-4311-A807-C86DA6640C90

P932

Q55260834-379D5CDC-FACC-4728-B0F1-12C43B583856

P356

P1433

P1476

Trial Watch: Chemotherapy with immunogenic cell death inducers.

@en

P2093

Alexander Eggermont

http://www.w3.org/2001/XMLSchema#string

Catherine Sautès-Fridman

http://www.w3.org/2001/XMLSchema#string

Isabelle Cremer

http://www.w3.org/2001/XMLSchema#string

P2860

A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death

Trial Watch: Tumor-targeting monoclonal antibodies in cancer therapy

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

Cancer immunoediting: from immunosurveillance to tumor escape

The three Es of cancer immunoediting

Calreticulin exposure dictates the immunogenicity of cancer cell death

Cyclophosphamide synergizes with type I interferons through systemic dendritic cell reactivation and induction of immunogenic tumor apoptosis

Trial watch: Cardiac glycosides and cancer therapy

P304

e27878

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/ONCI.27878

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Lorenzo Galluzzi

Laurence Zitvogel

Fernando Aranda

Erika Vacchelli

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267152859

http://www.w3.org/2001/XMLSchema#string

P698

24800173

http://www.w3.org/2001/XMLSchema#string

P921

P932

4008470

http://www.w3.org/2001/XMLSchema#string